Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-09-21
1991-04-09
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514183, 514210, 514212, 514218, 514254, 514292, A61K 31435, A61K 31445, A61K 31535
Patent
active
050065254
ABSTRACT:
Trans-(.+-.)-2-(substituted)-6-(substituted)-5,5a,6,7,8,9,9a,10-octahydropy rido[2,3-g]quinolines are useful in treating a variety of disorders including Parkinsonism, anxiety, depression, hypertension, glaucoma, sexual dysfunction, and prolactin mediated disorders such as galactorrhea, amenorrhea, prolactinoma and the inhibition of postpartum lactation.
REFERENCES:
patent: 3790577 (1974-02-01), Waring
patent: 4198415 (1980-04-01), Kornfeld et al.
patent: 4235909 (1980-11-01), Bach et al.
patent: 4501890 (1985-02-01), Nichols et al.
patent: 4537893 (1985-08-01), Titus et al.
patent: 4659832 (1987-04-01), Schaus et al.
Bach et al., J. Med. Chem., 23, 481, (1980).
Nordman et al., J. Med. Chem., 28(3), 367 (1985).
Eli Lilly and Company
Ramsuer Robert W.
Taylor Douglas J.
Whitaker Leroy
LandOfFree
Dopamine agonists method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dopamine agonists method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dopamine agonists method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2034618